Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2004

FR Doc 04-9660 [Federal Register: April 29, 2004 (Volume 69, Number 83)] [Notices] [Page 23538] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr29ap04-73]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Withdrawal of Application

By notice dated February 4, 2004, and published in the Federal Register on February 18, 2004 (68 FR 7656), IRIX Pharmaceuticals, Inc., 101 Technology Place, Florence, South Carolina 29501, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of methylphenidate (1724), a basic class of controlled substance listed in Schedule II. 

The firm planned to manufacture methylphenidate for sale to its customers. 

By letter dated February 18, 2004, IRIX Pharmaceuticals, Inc., requested that its registration as a Schedule II bulk manufacturer be retired. Therefore, IRIX Pharmaceuticals, Inc's renewal application to import the above listed controlled substance is hereby withdrawn.

Dated: March 29, 2004. 

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 04-9660 Filed 4-28-04; 8:45 am]

BILLING CODE 4410-09-M

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility